<text id="autogum_bio_doc98" title="Tom Jefferson (epidemiologist)" shortTile="tom-jefferson-epidemiologist" type="bio" dateCollected="2019-11-05" dateCreated="2014-12-08" dateModified="2019-08-05" sourceURL="https://en.wikipedia.org/wiki/Tom_Jefferson_%28epidemiologist%29" speakerList="none" speakerCount="0">
<head>Tom Jefferson (epidemiologist)</head>
<p><hi rend="bold">Tom Jefferson</hi> is a British epidemiologist, based in <ref target="https://en.wikipedia.org/wiki/Rome,_Italy">Rome, Italy</ref>,<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-atlantic-1">[1]</ref> who works for the <ref target="https://en.wikipedia.org/wiki/Cochrane_Collaboration">Cochrane Collaboration</ref>. Jefferson is an author and editor of the Cochrane Collaboration's acute respiratory infections group, as well as part of four other Cochrane groups.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-Cochrane2011-2">[2]</ref> He is also an advisor to the Italian National Agency for Regional Health Services.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-Cochrane2011-2">[2]</ref></p>
<p>In 1999 Jefferson was one of the founding members of the <ref target="https://en.wikipedia.org/wiki/Brighton_Collaboration">Brighton Collaboration</ref> along with Harald Heijbel, Ulrich Heininger, and Elisabeth Loupi.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-3">[3]</ref> He has worked on Cochrane reviews examining the effectiveness of the anti-viral <ref target="https://en.wikipedia.org/wiki/Oseltamivir">oseltamivir</ref> and the <ref target="https://en.wikipedia.org/wiki/Influenza_vaccine">influenza vaccine</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-NYT2013-4">[4]</ref></p>
<head>Notable work</head>
<p>In 2009 Jefferson was hired by the governments of Britain and Australia to update a <ref target="https://en.wikipedia.org/wiki/Systematic_review">systematic review</ref> of <ref target="https://en.wikipedia.org/wiki/Oseltamivir">oseltamivir</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-NYT2013-4">[4]</ref> Initially he had a great deal of trouble getting results of the original trials.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-NYT2013-4">[4]</ref> Previous researchers had published trials without seeing the underlying data and it appeared that some of the published papers used <ref target="https://en.wikipedia.org/wiki/Ghost_writers">ghost writers</ref>.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-NYT2013-4">[4]</ref> As the company, <ref target="https://en.wikipedia.org/wiki/Hoffmann-La_Roche">Roche</ref>, that did the trials refused to provide data for independent analysis, their conclusions in 2009 were that benefits could not be shown.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-NYT2013-4">[4]</ref></p>
<p>In 2011 Jefferson's team was provided 22,000 pages of data from the <ref target="https://en.wikipedia.org/wiki/European_Medicines_Agency">European Medicines Agency</ref> and Roche eventually provided 3,000 pages of data.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-NYT2013-4">[4]</ref> In 2012, Jefferson was the lead author of another Cochrane review of this data which concluded that oseltamivir did not reduce the number of hospitalizations caused by influenza. Jefferson said that this review also found no evidence that oseltamivir stopped complications from the disease.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-5">[5]</ref></p>
<p>His views about the effectiveness of influenza vaccines and his outspokenness about them are also controversial; at a 2007 meeting on pandemic preparedness he was shunned by other vaccine researchers and ate alone.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-atlantic-1">[1]</ref>  Reviews led by Jefferson have concluded that there is insufficient evidence to show that influenza vaccines reduce mortality or infection rates.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-6">[6]</ref> He has said that the studies claiming large reductions in mortality rates as a result of the influenza vaccine are "rubbish",<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-atlantic-1">[1]</ref> and that "influenza vaccines are about marketing and not science".<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-7">[7]</ref>  He has called repeatedly for placebo-controlled randomized clinical trials to prove the efficacy of flu vaccines, a position that most in the field hold as unethical.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-atlantic-1">[1]</ref>  His views on flu vaccines are opposed by the medical establishment.<ref target="https://en.wikipedia.org/wiki/Main_Page#cite_note-atlantic-1">[1]</ref></p>
<head>Publications</head>
<list type="unordered"><item>Jefferson, T; Alderson, P; Wager, E; Davidoff, F (5 June 2002). "Effects of editorial peer review: a systematic review". <hi rend="italic">JAMA</hi>. <hi rend="bold">287</hi> (21): 2784–6. <ref target="https://en.wikipedia.org/wiki/Digital_object_identifier">doi</ref>:<ref target="//doi.org/10.1001%2Fjama.287.21.2784">10.1001/jama.287.21.2784</ref>. <ref target="https://en.wikipedia.org/wiki/PubMed_Identifier">PMID</ref><ref target="//www.ncbi.nlm.nih.gov/pubmed/12038911">12038911</ref>.</item>
<item>Jefferson, T; Wager, E; Davidoff, F (5 June 2002). "Measuring the quality of editorial peer review". <hi rend="italic">JAMA</hi>. <hi rend="bold">287</hi> (21): 2786–90. <ref target="https://en.wikipedia.org/wiki/Digital_object_identifier">doi</ref>:<ref target="//doi.org/10.1001%2Fjama.287.21.2786">10.1001/jama.287.21.2786</ref>. <ref target="https://en.wikipedia.org/wiki/PubMed_Identifier">PMID</ref><ref target="//www.ncbi.nlm.nih.gov/pubmed/12038912">12038912</ref>.</item>
<item>Jefferson, T; Di Pietrantonj, C; Debalini, MG; Rivetti, A; Demicheli, V (July 2009). "Inactivated influenza vaccines: methods, policies, and politics". <hi rend="italic">Journal of Clinical Epidemiology</hi>. <hi rend="bold">62</hi> (7): 677–86. <ref target="https://en.wikipedia.org/wiki/Digital_object_identifier">doi</ref>:<ref target="//doi.org/10.1016%2Fj.jclinepi.2008.07.001">10.1016/j.jclinepi.2008.07.001</ref>. <ref target="https://en.wikipedia.org/wiki/PubMed_Identifier">PMID</ref><ref target="//www.ncbi.nlm.nih.gov/pubmed/19124222">19124222</ref>.</item>
<item>Jefferson, T.; Del Mar, C.; Dooley, L.; Ferroni, E.; Al-Ansary, L. A; Bawazeer, G. A; van Driel, M. L; Foxlee, R.; Rivetti, A. (22 September 2009). <ref target="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2190272">"Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review"</ref>. <hi rend="italic">BMJ</hi>. <hi rend="bold">339</hi> (sep21 1): b3675–b3675. <ref target="https://en.wikipedia.org/wiki/Digital_object_identifier">doi</ref>:<ref target="//doi.org/10.1136%2Fbmj.b3675">10.1136/bmj.b3675</ref>. <ref target="https://en.wikipedia.org/wiki/PubMed_Central">PMC</ref><ref target="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2190272">2190272</ref>.</item>
<item>Chan, An-Wen; Song, Fujian; Vickers, Andrew; Jefferson, Tom; Dickersin, Kay; Gøtzsche, Peter C; Krumholz, Harlan M; Ghersi, Davina; van der Worp, H Bart (January 2014). <ref target="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4533904">"Increasing value and reducing waste: addressing inaccessible research"</ref>. <hi rend="italic">The Lancet</hi>. <hi rend="bold">383</hi> (9913): 257–266. <ref target="https://en.wikipedia.org/wiki/Digital_object_identifier">doi</ref>:<ref target="//doi.org/10.1016%2FS0140-6736%2813%2962296-5">10.1016/S0140-6736(13)62296-5</ref>. <ref target="https://en.wikipedia.org/wiki/PubMed_Central">PMC</ref><ref target="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4533904">4533904</ref>. <ref target="https://en.wikipedia.org/wiki/PubMed_Identifier">PMID</ref><ref target="//www.ncbi.nlm.nih.gov/pubmed/24411650">24411650</ref>.</item>
<item>Doshi, P.; Jefferson, T. (2 March 2015). "The evidence base for new drugs". <hi rend="italic">BMJ</hi>. <hi rend="bold">350</hi> (mar02 6): h952–h952. <ref target="https://en.wikipedia.org/wiki/Digital_object_identifier">doi</ref>:<ref target="//doi.org/10.1136%2Fbmj.h952">10.1136/bmj.h952</ref>.</item></list>
</text>
